# FDA Inspection 1003136 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - February 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/7a3d220a-e2a0-4021-b6d6-18d1d0fe1ac9
Source feed: FDA_Inspections

> FDA Inspection 1003136 for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services on February 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003136
- Company Name: Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
- Inspection Date: 2017-02-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1321518 - 2026-06-10](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/412acb95-826f-4c54-ae58-76bfe6fdd681)
- [FDA Inspection 1321518 - 2026-06-10](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/98be2869-e2d8-4d6d-8f31-f8b092a80149)
- [FDA Inspection 1239754 - 2024-05-24](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/66bf6291-43c6-4007-aa3a-035315260b2e)
- [FDA Inspection 1239754 - 2024-05-24](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/3630bd0d-c3e4-4231-92a7-6a715c2696aa)
- [FDA Inspection 1218916 - 2023-09-27](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/30671712-4711-4ae1-ac69-3a9a86a3c601)

Company: https://www.keypedia.com/companies/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/a2a924d8-594c-4f2a-a998-5cbd4c06c983

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c